{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T11:21:12Z","timestamp":1722943272941},"reference-count":16,"publisher":"Japanese Circulation Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ Rep"],"published-print":{"date-parts":[[2022,2,10]]},"DOI":"10.1253\/circrep.cr-21-0122","type":"journal-article","created":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T22:08:54Z","timestamp":1642630134000},"page":"99-104","source":"Crossref","is-referenced-by-count":2,"title":["Rationale and Design of the Efficacy and Safety of Esaxerenone in Hypertensive Patients With Left Ventricular Hypertrophy (ESES-LVH) Study\u3000\u2015 Protocol for a Multicenter, Open-Label, Exploratory Interventional Study \u2015"],"prefix":"10.1253","volume":"4","author":[{"given":"Daisuke","family":"Sueta","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Science, Kumamoto University"},{"name":"Center for Metabolic Regulation of Healthy Aging, Graduate School of Medical Science, Kumamoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiichiro","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Science, Kumamoto University"},{"name":"Center for Metabolic Regulation of Healthy Aging, Graduate School of Medical Science, Kumamoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Usuku","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Science, Kumamoto University"},{"name":"Center for Metabolic Regulation of Healthy Aging, Graduate School of Medical Science, Kumamoto University"},{"name":"Molecular Laboratory, Graduate School of Medical Science, Kumamoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Science, Kumamoto University"},{"name":"Center for Metabolic Regulation of Healthy Aging, Graduate School of Medical Science, Kumamoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taishi","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Science, Kumamoto University"},{"name":"Center for Metabolic Regulation of Healthy Aging, Graduate School of Medical Science, Kumamoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunihiko","family":"Matsui","sequence":"additional","affiliation":[{"name":"Community, Family, and General Medicine, Faculty of Life Sciences, Graduate School of Medical Science, Kumamoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaaki","family":"Akasaka","sequence":"additional","affiliation":[{"name":"Primary Medical Science Department, Daiichi Sankyo Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhito","family":"Shiosakai","sequence":"additional","affiliation":[{"name":"Data Intelligence Department, Daiichi Sankyo Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kotaro","family":"Sugimoto","sequence":"additional","affiliation":[{"name":"Primary Medical Science Department, Daiichi Sankyo Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Tsujita","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Science, Kumamoto University"},{"name":"Center for Metabolic Regulation of Healthy Aging, Graduate School of Medical Science, Kumamoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the ESES-LVH Study Investigators","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. <i>N Engl J Med<\/i> 1990; 322: 1561\u20131566.","DOI":"10.1056\/NEJM199005313222203"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Muiesan ML, Salvetti M, Rizzoni D, Castellano M, Donato F, Agabiti-Rosei E. Association of change in left ventricular mass with prognosis during long-term antihypertensive treatment. <i>J Hypertens<\/i> 1995; 13: 1091\u20131095.","DOI":"10.1097\/00004872-199510000-00003"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium: Fibrosis and renin-angiotensin-aldosterone system. <i>Circulation<\/i> 1991; 83: 1849\u20131865.","DOI":"10.1161\/01.CIR.83.6.1849"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Tsutsui H, Isobe M, Ito H, Ito H, Okumura K, Ono M, et al. JCS 2017\/JHFS 2017 guideline on diagnosis and treatment of acute and chronic heart failure: Digest version. <i>Circ J<\/i> 2019; 83: 2084\u20132184.","DOI":"10.1253\/circj.CJ-19-0342"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Miller AB, Reichek N, St John Sutton M, Iyengar M, Henderson LS, Tarka EA, et al. Importance of blood pressure control in left ventricular mass regression. <i>J Am Soc Hypertens<\/i> 2010; 4: 302\u2013310.","DOI":"10.1016\/j.jash.2010.09.003"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Klingbeil AU, Schneider M, Martus P, Messerli FH, Schmieder RE. A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension. <i>Am J Med<\/i> 2003; 115: 41\u201346.","DOI":"10.1016\/S0002-9343(03)00158-X"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, et al. The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2019). <i>Hypertens Res<\/i> 2019; 42: 1235\u20131481.","DOI":"10.1038\/s41440-019-0284-9"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Bomback AS, Klemmer PJ. The incidence and implications of aldosterone breakthrough. <i>Nat Clin Pract Nephrol<\/i> 2007; 3: 486\u2013492.","DOI":"10.1038\/ncpneph0575"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Nishiyama A. Pathophysiological mechanisms of mineralocorticoid receptor-dependent cardiovascular and chronic kidney disease. <i>Hypertens Res<\/i> 2019; 42: 293\u2013300.","DOI":"10.1038\/s41440-018-0158-6"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Sueta D, Yamamoto E, Tsujita K. Mineralocorticoid receptor blockers: Novel selective nonsteroidal mineralocorticoid receptor antagonists. <i>Curr Hypertens Rep<\/i> 2020; 22: 21.","DOI":"10.1007\/s11906-020-1023-y"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure: Randomized Aldactone Evaluation Study Investigators. <i>N Engl J Med<\/i> 1999; 341: 709\u2013717.","DOI":"10.1056\/NEJM199909023411001"},{"key":"12","unstructured":"12. Catena C, Colussi G, Brosolo G, Iogna-Prat L, Sechi LA. Aldosterone and aldosterone antagonists in cardiac disease: What is known, what is new. <i>Am J Cardiovasc Dis<\/i> 2012; 2: 50\u201357."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Wan N, Rahman A, Nishiyama A. Esaxerenone, a novel nonsteroidal mineralocorticoid receptor blocker (MRB) in hypertension and chronic kidney disease. <i>J Hum Hypertens<\/i> 2021; 35: 148\u2013156.","DOI":"10.1038\/s41371-020-0377-6"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Ito S, Itoh H, Rakugi H, Okuda Y, Iijima S. Antihypertensive effects and safety of esaxerenone in patients with moderate kidney dysfunction. <i>Hypertens Res<\/i> 2021; 44: 489\u2013497.","DOI":"10.1038\/s41440-020-00585-y"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Belden Z, Deiuliis JA, Dobre M, Rajagopalan S. The role of the mineralocorticoid receptor in inflammation: Focus on kidney and vasculature. <i>Am J Nephrol<\/i> 2017; 46: 298\u2013314.","DOI":"10.1159\/000480652"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Imai Y, Nishiyama A, Sekino M, Aihara A, Kikuya M, Ohkubo T, et al. Characteristics of blood pressure measured at home in the morning and in the evening: The Ohasama study. <i>J Hypertens<\/i> 1999; 17: 889\u2013898.","DOI":"10.1097\/00004872-199917070-00004"}],"container-title":["Circulation Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circrep\/4\/2\/4_CR-21-0122\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T04:57:18Z","timestamp":1715230638000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circrep\/4\/2\/4_CR-21-0122\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,10]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1253\/circrep.cr-21-0122","relation":{},"ISSN":["2434-0790"],"issn-type":[{"type":"electronic","value":"2434-0790"}],"subject":[],"published":{"date-parts":[[2022,2,10]]},"article-number":"CR-21-0122"}}